CRISPR Therapeutics AG (CRSP)
40.72
+0.34
(+0.83%)
USD |
NASDAQ |
Dec 20, 16:00
40.87
+0.15
(+0.37%)
After-Hours: 20:00
CRISPR Therapeutics Total Liabilities (Quarterly): 316.47M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 6.609B |
| Lonza Group Ltd | 9.422B |
| AC Immune SA | 135.61M |
| Addex Therapeutics Ltd | 1.315M |
| NLS Pharmaceutics Ltd | 10.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.256B |
| Shareholders Equity (Quarterly) | 1.940B |